SCHEMBL56056

SCHEMBL56056

[C]1CC2C=CC=CC2N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2641486 0.65
SCHEMBL923707 0.63
SCHEMBL7946672 0.60
SCHEMBL152393 0.60
SCHEMBL182773 0.56
SCHEMBL5155320 0.56
SCHEMBL11984505 0.55
SCHEMBL1054620 0.54
SCHEMBL14138851 0.54
SCHEMBL1496265 0.54

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5083 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4337639-A1 NAMPT INHIBITORS AND USES THEREOF Remedy Plan, Inc. (US) 2024-03-20 EP claimed
WO-2023211938-A1 METHODS OF USING A (THIAZOLYL)BENZENESULFONAMIDE DERIVATIVE CYTEIR THERAPEUTICS, INC. (US) 2023-11-02 WO claimed
CN-116730980-A Compound and stereoisomer thereof, or pharmaceutically acceptable salt and application thereof 合肥工业大学智能制造技术研究院 2023-09-12 CN claimed
US-11649324-B2 Highly pure thionated polymers BRIMSTONE HOLDING LLC (US) 2023-05-16 US claimed
US-20230082167-A1 NOVEL TRICYCLIC COMPOUNDS ABBVIE INC (US) 2023-03-16 US claimed
EP-4112616-A1 RAD51 INHIBITORS Cyteir Therapeutics, Inc. (US) 2023-01-04 EP claimed
WO-2022241257-A1 NAMPT INHBITORS AND USES THEREOF REMEDY PLAN, INC. (US) 2022-11-17 WO claimed
CN-115028657-A Preparation method and product of 2-substituted indole spiro-compound 中国科学院上海药物研究所 2022-09-09 CN claimed
EP-3681884-B1 RAD51 INHIBITORS CYTEIR THERAPEUTICS INC (US) 2022-06-01 EP claimed
CN-114514023-A Methods of treating pancreatic cancer using RAD51 inhibitors 赛泰尔治疗公司 2022-05-17 CN claimed
US-6849629-B2 Heteroaromatic substituted sulfonyl or sulfoxide or thio-pyridazinone derivatives, useful for treating diabetic complications and cardiovascular disorders PFIZER, INC. (US) 2005-02-01 US claimed
US-20030162784-A1 Pyridazinone aldose reductase inhibitors MYLARI BANAVARA L (US) 2003-08-28 US claimed
US-20020143017-A1 Pyridazinone aldose reductase inhibitors MYLARI BANAVARA L (US) 2002-10-03 US claimed
US-6451938-B1 CATALYTIC COMPLEX FORMED BY ACTIVATING TRANSITION METAL COMPOUNDS COMPRISING CYCLOPENTADIENIDE ANIONS WHICH BEAR FUSED HETEROCYCLIC RINGS EXXON MOBIL CHEMICAL PATENTS INC. 2002-09-17 US claimed
US-6410533-B1 THERAPY FOR BACTERIA INFECTIONS GENZYME CORPORATION 2002-06-25 US claimed
US-4766210-A Antihypertensive lactams SUH JOHN T (US) 1988-08-23 US claimed
EP-0014880-B1 PHENOXYCARBOXYLIC ACID AMIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES BAYER AG (DE) 1982-09-22 EP claimed
US-4347246-A Antihypertensive lactams USV PHARMACEUTICAL CORPORATION (US) 1982-08-31 US claimed
EP-0014900-B1 CARBONYLALKYL ESTERS OF PHENOXYCARBOXYLIC ACIDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES AS WELL AS DEFOLIANTS AND DESICCANTS BAYER AG (DE) 1982-06-02 EP claimed
EP-0040332-A1 Antihypertensive lactams USV PHARMACEUTICAL CORPORATION (US) 1981-11-25 EP claimed